Work

P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.1201

Authors: R. Guo, I. Preeshagul, A. Schoenfeld, C. Mccarthy, A. Makhnin, A. Plodkowski, M. Ginsberg, M. Davare, L. Delasos, R. Somwar, M. Arcila, G. Riely, N. Rekhtman, M. Ladanyi, M. Kris, A. Drilon

Institutions: Memorial Sloan Kettering Cancer Center, Oregon Health & Science University, UConn Health, Cornell University, Weill Cornell Medicine

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981389381

FWCI: 0.165

Cites:

Cited by: 3

Related to: 10